Thursday - February 19, 2026

Acinetobacter Infections Pipeline Expands as 7+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | Omnix Medical, Roche, Telum Therapeutics, Spero Therapeutics

Acinetobacter Infections – Pipeline Insight, 2026 DelveInsight’s “Acinetobacter Infections – Pipeline Insight, 2026” report provides comprehensive insights about 8+ companies, including Omnix Medical, Roche, Telum Therapeutics, Spero Therapeutics, VenatoRx Pharmaceuticals, ABAC Therapeutics, and others, developing 10+ pipeline drugs in the … Continue reading

Metastatic Prostate Cancer Clinical Trial Pipeline Advances as 80+ Companies Develop 85+ Pipeline Drugs Across Multiple Stages, Finds DelveInsight | Merck, AstraZeneca, Syntrix Pharmaceuticals

Metastatic Prostate Cancer – Pipeline Insight, 2026 DelveInsight’s “Metastatic Prostate Cancer – Pipeline Insight, 2026” report provides comprehensive insights about 80+ companies including AstraZeneca, Arvinas, Daiichi Sankyo, Bristol Myers Squibb, Merck, MacroGenics, Seagen, Taiho Pharmaceutical, Modra Pharmaceuticals, Xencor, Point Biopharma, … Continue reading

Uveitis Clinical Trial Pipeline Expands as 15+ Companies Advance 15+ Targeted Ocular Inflammation Therapies Toward Market Entry, Finds DelveInsight | Santen, Clearside Biomedical, Tarsier Pharma

Uveitis – Pipeline Insight, 2026 DelveInsight’s “Uveitis – Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies, including Eli Lilly and Company, Santen Inc., Clearside Biomedical, Affibody, Eyevensys, Alcon Research, Panoptes Pharma, Tarsier Pharma, Eye Pharma, Apitope Technology, Mitotech, … Continue reading

Degenerative Disc Disease Clinical Trial Pipeline Strengthens as 15+ Companies Advance 15+ Regenerative and Non‑Surgical Therapies Toward Market Entry, Finds DelveInsight | Spine BioPharma, Biosplice

“Degenerative Disc Disease – Pipeline Insight, 2026 DelveInsight’s “Degenerative Disc Disease – Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies, including include Spine BioPharma, Inc., BioRestorative Therapies, Mesoblast Ltd., Biosplice Therapeutics, Causeway Therapeutics, AnGes Inc., DiscGenics, Kuros Biosciences, … Continue reading

Celiac Disease Clinical Trial Pipeline Gains Momentum as 25+ Companies Advance Novel Therapies Toward Market Entry: DelveInsight | Teva Pharmaceutical Industries, Barinthus Biotherapeutics, Topas

Celiac Disease – Pipeline Insight, 2026 DelveInsight’s “Celiac Disease – Pipeline Insight, 2026” report provides comprehensive insights about 25+ companies, including Teva Pharmaceutical Industries Ltd., Sanofi, Forte Biosciences, Inc., Takeda, Anokion, Entero Therapeutics, Amgen, Topas Therapeutics, Mozart Therapeutics Australia Pty … Continue reading

Bronchiectasis Clinical Trial Pipeline Expands as 15+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | AstraZeneca, Insmed, Boehringer Ingelheim, CSL, RedHill, Chies

Bronchiectasis – Pipeline Insight, 2026 DelveInsight’s “Bronchiectasis – Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies, including AstraZeneca, Insmed Incorporated, SolAeroMed, Boehringer Ingelheim, CSL Behring, Thirty Respiratory Limited, RedHill Biopharma Limited, Chiesi Farmaceutici S.p.A., Armata Pharmaceuticals, Alaxia, Parion … Continue reading

Thymidine Kinase 2 Deficiency Market to Grow Rapidly by 2034, DelveInsight Observes | UCB Biosciences

Thymidine Kinase 2 Deficiency Market Insights, Epidemiology, and Market Forecast – 2034 The Thymidine Kinase 2 Deficiency market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Thymidine Kinase … Continue reading

Friedreich’s Ataxia Clinical Trial Pipeline Expands as 10+ Companies Progress 10+ Novel Therapies Toward Market Entry, Finds DelveInsight | PTC Therapeutics, Retrotope, Reata Pharmaceuticals, Minoryx

Friedreich’s Ataxia – Pipeline Insight, 2026 DelveInsight’s “Friedreich’s Ataxia – Pipeline Insight, 2026” report provides comprehensive insights about 10+ companies including PTC Therapeutics, Retrotope, Reata Pharmaceuticals, Minoryx Therapeutics, Larimar Therapeutics, LEXEO Therapeutics, Exicure, StrideBio, Voyager Therapeutics, Lacerta Therapeutics and others, … Continue reading